Labviva provides an easy-to-use SaaS platform and marketplace that unifies the interface for product discovery and procurement and seamlessly connects suppliers, purchasers, allowing scientists to make better purchasing decisions. The funding will be used to accelerate deployment of Labviva’s platform at a number of global pharmaceutical and academic customers.
The Series A funding brings the total amount raised since inception to $30 million. Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures.
0 kommentar(er)
